realization of a part of clinical trial called Randomized, multicenter, double-blind, double-dummy, comparative study III with parallel groups to assess the efficacy, safety and tolerability of the combination of ceftazidime and avibactam (CAZ104) and metronidazole in the treatment of complicated intra-abdominal infections (cIAI) in hospitalized adult patients compared with meropenem.